Catalyst Wire Dossier Catalyst Wire Dossier

Velpatasvir

velpatasvir · Gilead Sciences
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Velpatasvir, covering 2013-08-29 to 2023-09-27. Get the full timeline:

Most recent: EMA Authorised: Vosevi (sofosbuvir;velpatasvir;voxilaprevi) — Gilead Sciences Ireland UC

See pricing